Overview

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Status:
Completed
Trial end date:
1998-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect, pharmacokinetics and dose proportionality of buprenorphine when administered to non-dependent opiate users. 1) To evaluate whether plasma concentrations of buprenorphine increase proportionally to buprenorphine dose. 2) To evaluate the dose-response of subjective and physiological effects of buprenorphine; and 3) To determine the safety of buprenorphine.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
Cincinnati MDRU
Treatments:
Buprenorphine